Program

 

The 13th Annual International Symposium on Liver & IBD Review Preliminary Program is available in the following formats:

View online Flipbook |Download/View PDF
Click here to register

Friday, January 17, 2020
6:00 pm – 10:00 pm Registration Open
Room: Pre-Function Area
6:00 pm – 10:30 pm President’s Welcome Dinner
Room: Whistler/Blackcomb
   
Saturday, January 18, 2020
7:00 am – 11:00 am Registration
Room:  Pre-Function Area
7:00 am – 9:30 am Breakfast
Room:  Whistler/Blackcomb
7:30 am – 7:35 am Welcome and Opening Remarks
Room:  Mont Tremblant I/II
Speaker: Dr. Imran Rasul

+/-

Imran Rasul, MD, HBSc., FRCP(C)
Gastroenterology
Trillium Health Partners
Endoscopy Lead - Credit Valley Hospital
Lecturer - University of Toronto
Director - WGTA Endoscopy
President - Ontario Association of Gastroenterology

Dr. Imran Rasul completed his undergraduate training at the University of Toronto in 1992. He went on to complete his Medical Degree, Internal Medicine and Gastroenterology training at the University of Toronto. Further training in Advanced Therapeutic Endoscopy was completed at University of Toronto. He has been practicing in Mississauga at the Credit Valley Hospital for the past seven years. Dr. Rasul has an interest in Advanced Endoscopy and is Chair of the Endoscopy Unit at Credit Valley Hospital.

7:35 am – 8:05 am Pre-Biologic work-up and Implications for Biologic Therapy in IBD
Room:  Mont Tremblant I/II
Speaker: Dr. Remo Panaccione

+/-

Remo Panaccione, MD, FRCP(C)
Director, Inflammatory Bowel Disease Clinic
Director, Gastrointestinal Research
Director of MD Admissions
Professor of Medicine
Cumming School of Medicine
University of Calgary

Dr. Panaccione is currently a Professor of Medicine, the Director of the Inflammatory Bowel Disease unit, Director of Gastroenterology Research and Associate Dean of UME Admissions at the University of Calgary

Dr. Panaccione graduated from the University of Western Ontario (London, Ontario) with a degree in Medicine in 1993.  He went on to complete his Internal Medicine and Gastroenterology training at the University of Western Ontario and advanced training in Inflammatory Bowel Disease at the Mayo Clinic in Rochester, Minnesota.  He joined the faculty of Medicine at the University of Calgary in 1999.

 He is an internationally recognized expert in inflammatory bowel disease. He has lectured nationally and internationally on various topics in inflammatory bowel disease and has delivered over 250 lectures in the last five years. He is the author of many peer-reviewed articles (~250) and book chapters (25) on inflammatory bowel disease.  He has published in and reviews for prestigious journals including NEJM, Lancet, Gastroenterology and Gut.   He sits on the editorial board of Inflammatory Bowel Diseases, JCC, APT, and the Canadian Journal of Gastroenterology.

He is presently the medical director for the Crohn’s and Colitis Canada (CCC) and sits on the Medical Advisory council for the Crohn’s and Colitis Foundation of Canada. He is the national chair of the CCC scholarship program.  He has been awarded the highest honour, the Finkelstein award by Crohn’s and Colitis Canada for his work in the field of IBD.  He is also an elected member of the International Organization of Inflammatory Bowel Disease (IOIBD) reflecting his status in the area. He was awarded the CAG Visiting Professor Award in 2016 for his contribution o the field of Gastroenterology in Canada
8:05 am – 8:25 am Viral Hepatitis in Patients Being Considered for Biologics
Room:  Mont Tremblant I/II
Speaker: Dr. Navjot Deol

+/-

Navjot Deol, MD, FRCP(C)

Dr. Navjot Deol completed her medical degree at the Royal College of Surgeons in Ireland. She trained in Internal Medicine at the University of Saskatchewan and completed her Gastroenterology training at Western University in London, Ontario. She subsequently completed a clinical Hepatology fellowship at the University of Toronto. She is currently working as a Clinical Associate at the Toronto Center for Liver Disease and as a community hepatologist in Newmarket, ON.   

 
Non-Viral Liver Disease in the IBD Patient
Room:  Mont Tremblant I/II
8:25 am – 8:45 am Liver Perspective
Moderator: Dr. Aliya Gulamhusein

+/-

Aliya Gulamhusein, MD, MPH, FRCP(C)

Dr. Aliya Gulamhusein completed her medical degree at the University of Western Ontario. She trained in  Internal Medicine and Gastroenterology at the University of Toronto and completed a clinical and research fellowship in Advanced Hepatology and liver transplantation at Mayo Clinic. She completed a Masters degree in Public Health at John’s Hopkins before being recruited back as an Assistant Professor and Clinician Investigator in the Division of Gastroenterology at the University of Toronto. She is co-lead of the Autoimmune Liver Disease Clinic at the Toronto Centre for Liver Disease, a dedicated program focused on optimizing care for patients with PBC, PSC, and autoimmune hepatitis and she is actively involved in international consortia studying these diseases. She received a Young Investigator Award from PSC Partners Canada and her aims are to improve risk stratification tools in the hopes of moving towards a personalized approach to care for patients with these diseases.  

8:45 am – 9:05 am IBD Perspective: How does having underlying liver problems affect the bowel?
Speaker: Dr. Remo Panaccione

+/-

Remo Panaccione, MD, FRCP(C)
Director, Inflammatory Bowel Disease Clinic
Director, Gastrointestinal Research
Director of MD Admissions
Professor of Medicine
Cumming School of Medicine
University of Calgary

Dr. Panaccione is currently a Professor of Medicine, the Director of the Inflammatory Bowel Disease unit, Director of Gastroenterology Research and Associate Dean of UME Admissions at the University of Calgary

Dr. Panaccione graduated from the University of Western Ontario (London, Ontario) with a degree in Medicine in 1993.  He went on to complete his Internal Medicine and Gastroenterology training at the University of Western Ontario and advanced training in Inflammatory Bowel Disease at the Mayo Clinic in Rochester, Minnesota.  He joined the faculty of Medicine at the University of Calgary in 1999.

 He is an internationally recognized expert in inflammatory bowel disease. He has lectured nationally and internationally on various topics in inflammatory bowel disease and has delivered over 250 lectures in the last five years. He is the author of many peer-reviewed articles (~250) and book chapters (25) on inflammatory bowel disease.  He has published in and reviews for prestigious journals including NEJM, Lancet, Gastroenterology and Gut.   He sits on the editorial board of Inflammatory Bowel Diseases, JCC, APT, and the Canadian Journal of Gastroenterology.

He is presently the medical director for the Crohn's and Colitis Canada (CCC) and sits on the Medical Advisory council for the Crohn's and Colitis Foundation of Canada. He is the national chair of the CCC scholarship program.  He has been awarded the highest honour, the Finkelstein award by Crohn's and Colitis Canada for his work in the field of IBD.  He is also an elected member of the International Organization of Inflammatory Bowel Disease (IOIBD) reflecting his status in the area. He was awarded the CAG Visiting Professor Award in 2016 for his contribution o the field of Gastroenterology in Canada
9:05 am – 9:25 am Panel Discussion
Moderator: Dr. Lee Roth

+/-

Lee Roth, MD, FRCP(C), DABIM, AGAF, FACP, MSc
Gastroenterologist, William Osler Health Centre
Director, Ontario Association of Gastroenterology

Dr. Lee Roth is a general gastroenterologist at William Osler Health System – Etobicoke General Hospital with an academic appointment at the University of Toronto. He practices in a wide variety of clinical settings including hospital‐based and out‐of‐hospital endoscopy units. He completed medical school, internal medicine training and gastroenterology fellowship at Western University after which he obtained a Master's in clinical epidemiology at McMaster University.

9:25 am – 9:45 am Managing Decompensated Liver Disease
Speaker: Dr. Marco Puglia

+/-

Marco Puglia, MD, FRCP(C) 
Associate Professor
Department of Medicine, Division of Gastroenterology
McMaster University

Dr. Marco Puglia is a Gastroenterologist and Hepatologist at McMaster University. He graduated from medical school at the University of Ottawa.  He completed Internal Medicine and Gastroenterology training at McMaster University. He then completed a fellowship in Liver Transplant at the University of Toronto.  He has a general Gastroenterology and Hepatology practice with a particular interest in the management of viral hepatitis, fatty liver disease, hepatocellular carcinoma and the pre- and post-liver transplant patient. His academic interests include teaching, where he currently holds the position of Director of Medical Foundations 2 of the undergraduate medical education programme at McMaster.  In addition, Marco is involved in clinical research and he is the Principal Investigator in several clinical trials in areas such as NASH, HCV and PSC. 

 
Post Liver Transplant Patients with IBD 
Room:  Mont Tremblant I/II
9:45 am – 10:05 am Liver Perspective
Speaker: Dr. Anouar Teriaky

+/-

Anouar Teriaky, MD MPH FRCP(C)
Assistant Professor of Medicine

Multi Organ Transplant Program
London Health Sciences Centre
Western University, London, Ontario

Dr. Anouar Teriaky is an Assistant Professor of Medicine at Western University, a clinician teacher in the Department of Medicine, Division of Gastroenterology and Hepatology. He is currently the interim medical director of liver transplant in the Multi-Organ Transplant Program at London Health Sciences Centre. He completed his Bachelor of Science with honours in biochemistry and Medical Degree at the University of Ottawa. He trained in internal medicine residency and gastroenterology fellowship at Western University. Dr. Teriaky completed further training in transplant and general hepatology at the University of Chicago Medical Center. He recently completed his Master of Public Health at Harvard University. His clinical interests include research in liver transplantation and hepatocellular carcinoma.

Presentation Overview

This presentation will discuss the causes of liver disease in patients with inflammatory bowel disease undergoing liver transplantation, the recurrence of liver disease post-transplant, management of immunosuppressive therapy, surveillance for malignancy post-transplant, and complications and outcomes in this population.

10:05 am – 10:25 am IBD Perspective
Speaker: Dr. Reena Khanna

+/-

Reena Khanna, MD, MSc., FRCP(C)
Associate Professor of Medicine
Department of Medicine, Division of Gastroenterology
University of Western Ontario
London Ontario Canada

Dr. Reena Khanna is an Associate Professor of Medicine at the University of Western Ontario, and a Clinician Researcher in the Program for Experimental Medicine. She completed her MD and Internal Medicine residency at the University of Western Ontario, Gastroenterology fellowship at McMaster University.   Dr. Khanna completed an advanced fellowship in inflammatory bowel disease (IBD) at the Cleveland Clinic, followed by a research fellowship in international IBD clinical trials at the University of Western Ontario.   She completed an MSc in clinical epidemiology at McMaster University.  Her clinical and research interest are clinical trial design, new therapeutics, outcome measures.  She has designed, conducted and published several studies, including the first cluster study in IBD.  Dr. Khanna holds international grants and most recently was awarded the Crohn’s Colitis Canada’s rising star award for her research contributions.

10:25 am – 10:45 am Panel Discussion
Moderator: Dr. Imran Rasul

+/-

Imran Rasul, MD, HBSc., FRCP(C)
Gastroenterology
Trillium Health Partners
Endoscopy Lead - Credit Valley Hospital
Lecturer - University of Toronto
Director - WGTA Endoscopy
President - Ontario Association of Gastroenterology

Dr. Imran Rasul completed his undergraduate training at the University of Toronto in 1992. He went on to complete his Medical Degree, Internal Medicine and Gastroenterology training at the University of Toronto. Further training in Advanced Therapeutic Endoscopy was completed at University of Toronto. He has been practicing in Mississauga at the Credit Valley Hospital for the past seven years. Dr. Rasul has an interest in Advanced Endoscopy and is Chair of the Endoscopy Unit at Credit Valley Hospital.

 
  Extended Break
 
3:00 pm – 3:30 pm Nutrition Break
Room:  Pre-Function Area
 
 
IBD Focus - Case Presentations with Expert Panel
Room:  Mont Tremblant I/II
3:30 pm – 3:50 pm Speaker: Dr. Smita Halder

+/-

Smita L. S. Halder, MBChB, MRCP, MRes, PhD
Associate Professor in Gastroenterology, McMaster University
Chair of the Medical Advisory Committee, HHS

Dr. Smita Halder is an Associate Professor at McMaster University and was appointed Chair of the Medical Advisory Committee (Chief of Staff) at Hamilton Health Sciences in June 2019.  Born in Manchester, UK, Smita obtained her medical degree from Cambridge and Edinburgh Universities. She completed her general medicine training in Edinburgh. After obtaining membership of the Royal College of Physicians of Edinburgh, she moved back to Manchester for her GI residency training. Smita was awarded a 4-year Medical Research Council Fellowship to pursue a PhD. This award included a year’s training at the Mayo Clinic, Rochester, USA. In 2008 she moved to Canada to pursue a 2-year post-doctoral IBD fellowship at Mount Sinai Hospital, Toronto.  She was appointed to the Division of Gastroenterology at McMaster University in 2010,and has also developed as a leader in healthcare. She is training to become the first Physician Executive Coach to serve Hamilton Health Sciences and McMaster University.

3:45 pm – 3:50 pm Mini Discussion
3:50 pm – 4:05 pm Speaker: Dr. Reena Khanna

+/-

Reena Khanna, MD, MSc., FRCP(C)
Associate Professor of Medicine
Department of Medicine, Division of Gastroenterology
University of Western Ontario
London Ontario Canada

Dr. Reena Khanna is an Associate Professor of Medicine at the University of Western Ontario, and a Clinician Researcher in the Program for Experimental Medicine. She completed her MD and Internal Medicine residency at the University of Western Ontario, Gastroenterology fellowship at McMaster University.   Dr. Khanna completed an advanced fellowship in inflammatory bowel disease (IBD) at the Cleveland Clinic, followed by a research fellowship in international IBD clinical trials at the University of Western Ontario.   She completed an MSc in clinical epidemiology at McMaster University.  Her clinical and research interest are clinical trial design, new therapeutics, outcome measures.  She has designed, conducted and published several studies, including the first cluster study in IBD.  Dr. Khanna holds international grants and most recently was awarded the Crohn's Colitis Canada's rising star award for her research contributions.

4:05 pm – 4:10 pm Mini Discussion
4:10 pm – 4:25 pm Speaker: Dr. Laura Targownik

+/-

Laura Targownik, MD, MSHS, FRCP(C)
Associate Professor of Medicine
Departmental Division Director (Gastroenterology), University of Toronto
Chair for Diversity and Equity, Canadian Association of Gastroenterology
Staff Gastroenterologist, Mount Sinai Hospital (Toronto)

Dr. Laura Targownik is the Division Director of Gastroenterology at the University of Toronto, and has her clinical practice with the Mount Sinai Hospital Inflammatory Bowel Disease Program. She relocated to Toronto from Winnipeg 6 month ago after 16 years in the actual Centre of the Canada, the last 2 as the Section Head for Gastroenterology at the University of Manitoba. Her research is focused mostly on the assessing the risks and benefits of biologic therapy in inflammatory bowel disease. She is on the Scientific Medical Advisory Committee for Crohn's and Colitis Canada and also serves as a Review Committee Member for the Canadian Institutes of Health Research.

Presentation Overview

My case is going to focus on a rare condition that is actually a form of Inflammatory Bowel Disease, even if we don't actually think of It as such. The presentation consists of a review of the case with pictures, and a short review of the etiology, pathophysiology, presentation, and treatment of this condition. ​

4:25 pm – 4:30 pm Mini Discussion
4:30 pm – 4:45 pm Speaker: Dr. Adam Weizman

+/-

Adam V. Weizman, MD, MSc, FRCP(C)
Division of Gastroenterology
Mount Sinai Hospital
Assistant Professor of Medicine
University of Toronto

Dr. Weizman is a gastroenterologist at Mount Sinai Hospital in Toronto, Ontario and an Assistant Professor of Medicine at the University of Toronto. He received his medical degree from the University of Manitoba and subsequently did a Residency in Internal Medicine and Fellowship in Gastroenterology at the University of Toronto. He completed the Advanced Fellowship in Inflammatory Bowel Diseases at Cedars-Sinai Medical Center in Los Angeles, California and a Master's degree (MSc) in Quality Improvement and Patient Safety from the Institute of Health Policy, Evaluation, and Management at the University of Toronto.  His research interests include healthcare quality and health outcomes, with a focus on inflammatory bowel disease (IBD). Dr. Weizman is the Medical Director of the Inflammatory Bowel Diseases Centre at Mount Sinai Hospital and Head of Quality and Patient Safety for the division of gastroenterology at Mount Sinai Hospital and the University Health Network.

4:45 pm – 4:50 pm Mini Discussion
4:50 pm – 5:00 pm Panel Discussion
Room:  Mont Tremblant I/II
Moderator: Dr. Emily Ching

+/-

Emily Ching, MD, FRCP(C)
GI Health Centre
Treasurer, Ontario Association of Gastroenterology

Dr. Emily Ching received her medical degree at McMaster University. She then completed her residency in Internal Medicine at the University of Toronto. She is a recent gastroenterology training graduate from McMaster University in 2010, where she also served as a chief gastroenterology resident.

Upon completing her gastroenterology training, Dr. Ching has done gastroenterology locum at Oakville Trafalgar Memorial Hospital. She also worked at various outpatient clinics while being a part-time gastroenterology consultant at Baycrest Geriatric Centre in the Greater Toronto area. With the recent change in job climate in gastroenterology, she embraced the challenge to the new paradigm shift and co-found an outpatient-based gastroenterology clinic, GI Health Centre, along with Dr. Sapna Makhija and Dr. Avantika Marwaha in Burlington, Ontario, in the summer of 2012. Dr. Ching and her partners strive to shorten healthcare wait time while maintaining patient follow up and continuity of care.

5:00 pm – 5:00 pm Closing Remarks
Room:  Mont Tremblant I/II
Speaker: Dr. Imran Rasul

+/-

Imran Rasul, MD, HBSc., FRCP(C)
Gastroenterology
Trillium Health Partners
Endoscopy Lead - Credit Valley Hospital
Lecturer - University of Toronto
Director - WGTA Endoscopy
President - Ontario Association of Gastroenterology

Dr. Imran Rasul completed his undergraduate training at the University of Toronto in 1992. He went on to complete his Medical Degree, Internal Medicine and Gastroenterology training at the University of Toronto. Further training in Advanced Therapeutic Endoscopy was completed at University of Toronto. He has been practicing in Mississauga at the Credit Valley Hospital for the past seven years. Dr. Rasul has an interest in Advanced Endoscopy and is Chair of the Endoscopy Unit at Credit Valley Hospital.

 
6:00 pm – 10:30 pm Children's Program
Room:  Mont Tremblant I
6:30 pm – 11:30 pm President's Closing Dinner
Room:  Whistler/Blackcomb
   
Sunday, January 19, 2020
7:00 am – 10:00 am Registration Open
Room:  Pre-Function Area
7:00 am – 9:30 am Breakfast
Room:  Whistler/Blackcomb
 
8:00 am – 8:45 am Post AASLD Update
Room:  Mont Tremblant I/II
Speaker: Dr. Hemant Shah

+/-

Hemant Shah, MD, MScCH, HPTE, FRCP(C)
Education Director, Francis Family Liver Clinic, Toronto Western Hospital
Assistant Professor, University of Toronto
Secretary, Ontario Association of Gastroenterology

Dr. Hemant Shah is an Assistant Professor, Staff Hepatologist and Clinic Director at the Francis Family Liver Clinic, Toronto Western Hospital, University of Toronto. His clinical focus is viral liver disease and he maintains a busy teaching practice. In addition to clinical care, Dr. Shah is actively engaged in projects to develop innovative models of care for viral hepatitis, progress interprofessional collaboration and improve knowledge levels amongst primary care and specialty providers. He also serves as Program Director of the Hepatology Fellowship which trains three to five clinical and research fellows annually. Dr. Shah has graduate training in Health Practitioner Education.  

8:45 am – 9:00 am Discussion

9:00 am – 10:00 am

9:00 am – 9:20 am

IBD Focus - Case Presentations with Expert Panel
Room:  Mont Tremblant I/II

Liver Cases:

  • Dr. Hemant Shah

    +/-

    Hemant Shah, MD, MScCH, HPTE, FRCP(C)
    Education Director, Francis Family Liver Clinic, Toronto Western Hospital
    Assistant Professor, University of Toronto
    Secretary, Ontario Association of Gastroenterology

    Dr. Hemant Shah is an Assistant Professor, Staff Hepatologist and Clinic Director at the Francis Family Liver Clinic, Toronto Western Hospital, University of Toronto. His clinical focus is viral liver disease and he maintains a busy teaching practice. In addition to clinical care, Dr. Shah is actively engaged in projects to develop innovative models of care for viral hepatitis, progress interprofessional collaboration and improve knowledge levels amongst primary care and specialty providers. He also serves as Program Director of the Hepatology Fellowship which trains three to five clinical and research fellows annually. Dr. Shah has graduate training in Health Practitioner Education.  

9:20 am – 9:40 am

IBD Cases

  • Dr. James Gregor

    +/-

    James C. Gregor, MD, FRCP(C)
    Victoria Hospital Site Chief, London Health Sciences Centre
    Associate Chair, Western University
    Professor of Medicine, Department of Medicine

    Dr. James C. Gregor is a Professor of Medicine in the Departments of Medicine in the Schulich School of Medicine and Dentistry at Western University.

    Dr. Gregor graduated from the University of Western Ontario in 1988, and specialized in Internal Medicine and Gastroenterology.   He did further training in Clinical Epidemiology and Health Economics at the University of Toronto.

    Dr. Gregor joined the Medical Staff at The London Health Sciences Centre in 1995.  He served as Program Director for the Division of Gastroenterology from 1998 to 2009.  Currently he is the Site Chief for the Department of Medicine at the LHSC-Victoria Hospital, Associate Chair of Medicine at Western University.

    Dr. Gregor is past President of the Ontario Association of Gastroenterology and he is past Chair of the Specialty Committee in Gastroenterology for the Royal College of Physicians & Surgeons of Canada.

    His research interests include therapeutic endoscopy, inflammatory bowel disease, celiac disease and economic analysis and quality of life assessments in Gastroenterology.

Expert Panel Discussion

  • Dr. James Gregor

    +/-

    James C. Gregor, MD, FRCP(C)
    Victoria Hospital Site Chief, London Health Sciences Centre
    Associate Chair, Western University
    Professor of Medicine, Department of Medicine

    Dr. James C. Gregor is a Professor of Medicine in the Departments of Medicine in the Schulich School of Medicine and Dentistry at Western University.

    Dr. Gregor graduated from the University of Western Ontario in 1988, and specialized in Internal Medicine and Gastroenterology.   He did further training in Clinical Epidemiology and Health Economics at the University of Toronto.

    Dr. Gregor joined the Medical Staff at The London Health Sciences Centre in 1995.  He served as Program Director for the Division of Gastroenterology from 1998 to 2009.  Currently he is the Site Chief for the Department of Medicine at the LHSC-Victoria Hospital, Associate Chair of Medicine at Western University.

    Dr. Gregor is past President of the Ontario Association of Gastroenterology and he is past Chair of the Specialty Committee in Gastroenterology for the Royal College of Physicians & Surgeons of Canada.

    His research interests include therapeutic endoscopy, inflammatory bowel disease, celiac disease and economic analysis and quality of life assessments in Gastroenterology.

  • Dr. Hemant Shah

    +/-

    Hemant Shah, MD, MScCH, HPTE, FRCP(C)
    Education Director, Francis Family Liver Clinic, Toronto Western Hospital
    Assistant Professor, University of Toronto
    Secretary, Ontario Association of Gastroenterology

    Dr. Hemant Shah is an Assistant Professor, Staff Hepatologist and Clinic Director at the Francis Family Liver Clinic, Toronto Western Hospital, University of Toronto. His clinical focus is viral liver disease and he maintains a busy teaching practice. In addition to clinical care, Dr. Shah is actively engaged in projects to develop innovative models of care for viral hepatitis, progress interprofessional collaboration and improve knowledge levels amongst primary care and specialty providers. He also serves as Program Director of the Hepatology Fellowship which trains three to five clinical and research fellows annually. Dr. Shah has graduate training in Health Practitioner Education.  

  • Dr. Remo Panaccione

    +/-

    Remo Panaccione, MD, FRCP(C)
    Director, Inflammatory Bowel Disease Clinic
    Director, Gastrointestinal Research
    Director of MD Admissions
    Professor of Medicine
    Cumming School of Medicine
    University of Calgary

    Dr. Panaccione is currently a Professor of Medicine, the Director of the Inflammatory Bowel Disease unit, Director of Gastroenterology Research and Associate Dean of UME Admissions at the University of Calgary

    Dr. Panaccione graduated from the University of Western Ontario (London, Ontario) with a degree in Medicine in 1993.  He went on to complete his Internal Medicine and Gastroenterology training at the University of Western Ontario and advanced training in Inflammatory Bowel Disease at the Mayo Clinic in Rochester, Minnesota.  He joined the faculty of Medicine at the University of Calgary in 1999.

     He is an internationally recognized expert in inflammatory bowel disease. He has lectured nationally and internationally on various topics in inflammatory bowel disease and has delivered over 250 lectures in the last five years. He is the author of many peer-reviewed articles (~250) and book chapters (25) on inflammatory bowel disease.  He has published in and reviews for prestigious journals including NEJM, Lancet, Gastroenterology and Gut.   He sits on the editorial board of Inflammatory Bowel Diseases, JCC, APT, and the Canadian Journal of Gastroenterology.

    He is presently the medical director for the Crohn's and Colitis Canada (CCC) and sits on the Medical Advisory council for the Crohn's and Colitis Foundation of Canada. He is the national chair of the CCC scholarship program.  He has been awarded the highest honour, the Finkelstein award by Crohn's and Colitis Canada for his work in the field of IBD.  He is also an elected member of the International Organization of Inflammatory Bowel Disease (IOIBD) reflecting his status in the area. He was awarded the CAG Visiting Professor Award in 2016 for his contribution o the field of Gastroenterology in Canada
  • Dr. Marco Puglia

    +/-

    Marco Puglia, MD, FRCP(C) 
    Associate Professor
    Department of Medicine, Division of Gastroenterology
    McMaster University

    Dr. Marco Puglia is a Gastroenterologist and Hepatologist at McMaster University. He graduated from medical school at the University of Ottawa.  He completed Internal Medicine and Gastroenterology training at McMaster University. He then completed a fellowship in Liver Transplant at the University of Toronto.  He has a general Gastroenterology and Hepatology practice with a particular interest in the management of viral hepatitis, fatty liver disease, hepatocellular carcinoma and the pre- and post-liver transplant patient. His academic interests include teaching, where he currently holds the position of Director of Medical Foundations 2 of the undergraduate medical education programme at McMaster.  In addition, Marco is involved in clinical research and he is the Principal Investigator in several clinical trials in areas such as NASH, HCV and PSC. 

  • Dr. Reena Khanna

    +/-

    Reena Khanna, MD, MSc., FRCP(C)
    Associate Professor of Medicine
    Department of Medicine, Division of Gastroenterology
    University of Western Ontario
    London Ontario Canada

    Dr. Reena Khanna is an Associate Professor of Medicine at the University of Western Ontario, and a Clinician Researcher in the Program for Experimental Medicine. She completed her MD and Internal Medicine residency at the University of Western Ontario, Gastroenterology fellowship at McMaster University.   Dr. Khanna completed an advanced fellowship in inflammatory bowel disease (IBD) at the Cleveland Clinic, followed by a research fellowship in international IBD clinical trials at the University of Western Ontario.   She completed an MSc in clinical epidemiology at McMaster University.  Her clinical and research interest are clinical trial design, new therapeutics, outcome measures.  She has designed, conducted and published several studies, including the first cluster study in IBD.  Dr. Khanna holds international grants and most recently was awarded the Crohn's Colitis Canada's rising star award for her research contributions.

  • Dr. Smita Halder

    +/-

    Smita L. S. Halder, MBChB, MRCP, MRes, PhD
    Associate Professor in Gastroenterology, McMaster University
    Chair of the Medical Advisory Committee, HHS

    Dr. Smita Halder is an Associate Professor at McMaster University and was appointed Chair of the Medical Advisory Committee (Chief of Staff) at Hamilton Health Sciences in June 2019.  Born in Manchester, UK, Smita obtained her medical degree from Cambridge and Edinburgh Universities. She completed her general medicine training in Edinburgh. After obtaining membership of the Royal College of Physicians of Edinburgh, she moved back to Manchester for her GI residency training. Smita was awarded a 4-year Medical Research Council Fellowship to pursue a PhD. This award included a year's training at the Mayo Clinic, Rochester, USA. In 2008 she moved to Canada to pursue a 2-year post-doctoral IBD fellowship at Mount Sinai Hospital, Toronto.  She was appointed to the Division of Gastroenterology at McMaster University in 2010,and has also developed as a leader in healthcare. She is training to become the first Physician Executive Coach to serve Hamilton Health Sciences and McMaster University.

  • Dr. Laura Targownik

    +/-

    Laura Targownik, MD, MSHS, FRCP(C)
    Associate Professor of Medicine
    Departmental Division Director (Gastroenterology), University of Toronto
    Chair for Diversity and Equity, Canadian Association of Gastroenterology
    Staff Gastroenterologist, Mount Sinai Hospital (Toronto)

    Dr. Laura Targownik is the Division Director of Gastroenterology at the University of Toronto, and has her clinical practice with the Mount Sinai Hospital Inflammatory Bowel Disease Program. She relocated to Toronto from Winnipeg 6 month ago after 16 years in the actual Centre of the Canada, the last 2 as the Section Head for Gastroenterology at the University of Manitoba. Her research is focused mostly on the assessing the risks and benefits of biologic therapy in inflammatory bowel disease. She is on the Scientific Medical Advisory Committee for Crohn's and Colitis Canada and also serves as a Review Committee Member for the Canadian Institutes of Health Research.

  • Dr. Adam Weizman

    +/-

    Adam V. Weizman, MD, MSc, FRCP(C)
    Division of Gastroenterology
    Mount Sinai Hospital
    Assistant Professor of Medicine
    University of Toronto

    Dr. Weizman is a gastroenterologist at Mount Sinai Hospital in Toronto, Ontario and an Assistant Professor of Medicine at the University of Toronto. He received his medical degree from the University of Manitoba and subsequently did a Residency in Internal Medicine and Fellowship in Gastroenterology at the University of Toronto. He completed the Advanced Fellowship in Inflammatory Bowel Diseases at Cedars-Sinai Medical Center in Los Angeles, California and a Master's degree (MSc) in Quality Improvement and Patient Safety from the Institute of Health Policy, Evaluation, and Management at the University of Toronto.  His research interests include healthcare quality and health outcomes, with a focus on inflammatory bowel disease (IBD). Dr. Weizman is the Medical Director of the Inflammatory Bowel Diseases Centre at Mount Sinai Hospital and Head of Quality and Patient Safety for the division of gastroenterology at Mount Sinai Hospital and the University Health Network.

  • Dr. Anouar Teriaky

    +/-

    Anouar Teriaky, MD MPH FRCP(C)
    Assistant Professor of Medicine

    Multi Organ Transplant Program
    London Health Sciences Centre
    Western University, London, Ontario

    Dr. Anouar Teriaky is an Assistant Professor of Medicine at Western University, a clinician teacher in the Department of Medicine, Division of Gastroenterology and Hepatology. He is currently the interim medical director of liver transplant in the Multi-Organ Transplant Program at London Health Sciences Centre. He completed his Bachelor of Science with honours in biochemistry and Medical Degree at the University of Ottawa. He trained in internal medicine residency and gastroenterology fellowship at Western University. Dr. Teriaky completed further training in transplant and general hepatology at the University of Chicago Medical Center. He recently completed his Master of Public Health at Harvard University. His clinical interests include research in liver transplantation and hepatocellular carcinoma.

  • Dr. Navjot Deol

    +/-

    Navjot Deol, MD, FRCP(C)

    Dr. Navjot Deol completed her medical degree at the Royal College of Surgeons in Ireland. She trained in Internal Medicine at the University of Saskatchewan and completed her Gastroenterology training at Western University in London, Ontario. She subsequently completed a clinical Hepatology fellowship at the University of Toronto. She is currently working as a Clinical Associate at the Toronto Center for Liver Disease and as a community hepatologist in Newmarket, ON.   

  • Dr. Aliya Gulamhusein

    +/-

    Aliya Gulamhusein, MD, MPH, FRCP(C)

    Dr. Aliya Gulamhusein completed her medical degree at the University of Western Ontario. She trained in  Internal Medicine and Gastroenterology at the University of Toronto and completed a clinical and research fellowship in Advanced Hepatology and liver transplantation at Mayo Clinic. She completed a Masters degree in Public Health at John's Hopkins before being recruited back as an Assistant Professor and Clinician Investigator in the Division of Gastroenterology at the University of Toronto. She is co-lead of the Autoimmune Liver Disease Clinic at the Toronto Centre for Liver Disease, a dedicated program focused on optimizing care for patients with PBC, PSC, and autoimmune hepatitis and she is actively involved in international consortia studying these diseases. She received a Young Investigator Award from PSC Partners Canada and her aims are to improve risk stratification tools in the hopes of moving towards a personalized approach to care for patients with these diseases.  

9:40 am – 10:00 am

Panel Discussion
Moderator: Dr. James Gregor

+/-

James C. Gregor, MD, FRCP(C)
Victoria Hospital Site Chief, London Health Sciences Centre
Associate Chair, Western University
Professor of Medicine, Department of Medicine

Dr. James C. Gregor is a Professor of Medicine in the Departments of Medicine in the Schulich School of Medicine and Dentistry at Western University.

Dr. Gregor graduated from the University of Western Ontario in 1988, and specialized in Internal Medicine and Gastroenterology.   He did further training in Clinical Epidemiology and Health Economics at the University of Toronto.

Dr. Gregor joined the Medical Staff at The London Health Sciences Centre in 1995.  He served as Program Director for the Division of Gastroenterology from 1998 to 2009.  Currently he is the Site Chief for the Department of Medicine at the LHSC-Victoria Hospital, Associate Chair of Medicine at Western University.

Dr. Gregor is past President of the Ontario Association of Gastroenterology and he is past Chair of the Specialty Committee in Gastroenterology for the Royal College of Physicians & Surgeons of Canada.

His research interests include therapeutic endoscopy, inflammatory bowel disease, celiac disease and economic analysis and quality of life assessments in Gastroenterology.

 
10:00 am - 10:05 am Closing Remarks
Speaker: Dr. David Morgan
Room:  Mont Tremblant I/II

+/-

David Morgan, MD, MSc., FRCP(C)
Vice President, OAG
Head, Service of Gastroenterology
St. Joseph's Healthcare, Hamilton
Associate Professor, Division of Gastroenterology
McMaster University

Dr. David Morgan completed his undergraduate training in Human Genetics at McGill University. He did graduate studies including a Masters in Population Genetics. His undergraduate medical studies were completed at McMaster University and Post Graduate studies including Internal Medicine and Gastroenterology, were also completed at McMaster. Dr. Morgan took an additional fellowship year with special attention paid to advanced endoscopic techniques including YAG laser.

Dr. Morgan has published on topics such as GI Bleeding, Quality of Life in Cancer Care, Use of Proton Pump Inhibitors and The Prevention of Bleeding from GI Vascular Lesions. Dr. Morgan has participated on several CAG Consensus Panels dealing with such topics as CRC Screening. Dr. Morgan is a member of several international societies, is a Past President of the Canadian Association of Gastroenterology and is the current Vice President of the Ontario Association of Gastroenterology. Dr. Morgan is an Associate Editor for the ACP Journal Club and Evidence Based Medicine and has acted as a reviewer for many journals.

Dr. Morgan is on the Faculty at McMaster University and is involved in teaching at the undergraduate and post-graduate levels. He serves on many university and hospital committees. Dr. Morgan is Head of the Service of Gastroenterology and Deputy Chief of Medicine at St. Joseph's Hospital, Hamilton.

 

 


© 2020 Ontario Association of Gastroenterology
^